Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Chicago | 715 Studies

Clinical Trials Breast CancerChicago

Breast Cancer Clinical Trials in Chicago

Find 715 clinical trials for breast cancer near Chicago, Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 481-500 of 715 trials

CompletedMargetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast CancerThe purpose of this study is to determine whether patients with metastatic breast cancer treated with margetuximab plus chemotherapy have longer progression free survival (PFS)…NCT02492711·Chandler, Arizona and 166 others

Breast Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedChemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2Randomized phase II trial to study the effectiveness of chemotherapy with paclitaxel and the monoclonal antibody trastuzumab followed by chemotherapy in treating women who have…NCT00003992·Palo Alto, California and 44 others

CompletedCaptopril in Treating Patients Undergoing Bone Marrow or Stem Cell TransplantationRATIONALE: Captopril may protect the lungs from the side effects of bone marrow or stem cell transplantation.NCT00004230·Chicago, Illinois

Active not recruitingUnderstanding and Predicting Breast Cancer Events After TreatmentThis study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not…NCT02791581·Birmingham, Alabama and 65 others

WithdrawnCirculating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast CancerThis clinical trial studies how well circulating tumor deoxyribonucleic acid (ctDNA) based minimal residual disease (MRD) detection works for patients with early-stage breast…NCT07136493·Goodyear, Arizona and 4 others

CompletedS1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone TherapyRATIONALE: Duloxetine hydrochloride may lessen muscle, bone, and joint pain caused by hormone therapy.NCT01598298·Anchorage, Alaska and 713 others

CompletedTransdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyThis randomized trial studies transdermal or oral telapristone acetate in treating patients undergoing surgery to remove the breast (mastectomy).NCT02314156·West Hollywood, California and 2 others

UnknownLetrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes.NCT00382070·Anniston, Alabama and 805 others

CompletedTherapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast CancerThe main purpose is to learn if adding bevacizumab to standard chemotherapy and trastuzumab to treat HER2-positive breast cancer will affect heart function.NCT00464646·Huntsville, Alabama and 35 others

CompletedTrial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast CancerTo determine whether the combination MM-121 + Exemestane in ER+ and/or PR+ breast cancer patients is more effective than Exemestane aloneNCT01151046·Birmingham, Alabama and 32 others

CompletedA Safety Study of SGN-LIV1A in Breast Cancer PatientsThis study will examine the safety and tolerability of ladiratuzumab vedotin (LV) in patients with metastatic breast cancer.NCT01969643·Birmingham, Alabama and 37 others

RecruitingA Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload…NCT06926868·Hot Springs, Arkansas and 294 others

CompletedContinued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerClinical trial in breast cancer patients with bone metastases pretreated for approximately 1 year with a standard zoledronic acid regimen.NCT00320710·Anchorage, Alaska and 91 others

RecruitingTesting Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialThis phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone therapy plus ribociclib for the treatment of patients with high…NCT07391774·Jonesboro, Arkansas and 203 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

CompletedPaclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticThis randomized phase III studies how well two different regimens of paclitaxel with or without trastuzumab works in treating patients with or without HER-2/Neu breast cancer that…NCT00003440·Chicago, Illinois

CompletedA Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisThe purpose of the study is to investigate the response rate for triple negative breast cancer patients with brain metastasis when INIPARIB is used in combination with irinotecan.NCT01173497·Birmingham, Alabama and 12 others

CompletedChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004900·Chicago, Illinois

CompletedA Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesThis is an open-label, non-randomized, multicenter, dose-escalation and expansion study in patients with selected solid tumors.NCT04440943·Atlanta, Georgia and 4 others

CompletedStudy to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid TumorsThe purpose of this study was to assess the safety of the combination of relacorilant (CORT125134), a novel glucocorticoid receptor (GR) antagonist, and nab- paclitaxel in…NCT02762981·Scottsdale, Arizona and 3 others

PreviousPage 25 of 36Next

Other Conditions in Chicago

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma